Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Similar documents
Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

Laboratory Service Report

The Drug Testing Process. Employer or Practice

INTERPATH LABORATORY, INC. TEST UPDATES

Urine Drug Testing Methods 3-5

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Substance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004

Pain Medication Management Program Supports Patient Outcomes and Adherence

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

Forensic Toxicology Scope of Testing and Detection Limits

LC Application Note. Dangerous driver?

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Schedule of Accreditation

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Pain Medication Management Program Monitors Patient Compliance

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

Fastect II Drug Screen Dipstick Test Training and Certification Program

Urine Opioid Dependency Panel (UODP) 1

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

Urine Drug Screening: The Essentials of Interpretation

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Drug Adherence Assessment Report

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

European Guidelines for Workplace Drug Testing in UrineandOral fluid

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Keep It Clean. Solid Phase Extraction Solutions for Drugs of Abuse Analysis. Neutral Drugs of Abuse Basic Drugs of Abuse

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

nextgen precision Test Report

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

DOF. Scheme Description. Drugs in Oral Fluid Scheme

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Drugs of Abuse I Serum

New Test Announcements

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

Controlled Substance Monitoring in the Age of the Opioid Epidemic

TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE:

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

ToxCup Drug Screen Cup Step-by Step Instructions

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management

Urine drug testing it s not always crystal clear

Multi-Drug Screen Test

Drug Profiles of Apprehended Drivers in Victoria

Testing for Controlled Substances

Rapid Alcohol Screening Devices. p19

DRUGS OF ABUSE

Urine Drug Analysis Test No Summary Report

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

PAML interface maintenance bulletin 5/25/2012 ATTN: INTERFACE DATA MANAGER

Rapid Drug Test Cup Step-by Step Instructions

Validation of an Automated Method to Remove

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry

Cutoff levels for hydrocodone in a blood test

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Why Drug Test in the Retail Industry? 2010 Retail Inventory Shrinkage 3. Employee Theft $16.2B (43.7%)

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

PARTICIPANT GENERAL INFORMATION

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

2013 Clinical drug and alcohol testing solutions. Product Catalog. CLIA-waived point of care test devices

DrugConfirm Advanced Urine Dip Cards.

DAU. Scheme Description. Drugs of Abuse in Urine Proficiency Testing Scheme

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

T R A I N I N G G U I D E

Dynacare Laboratories

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

Transcription:

Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle Specimen Volume: 30 ml Collection Instructions: 1. Collect a random urine specimen. 2. Submit 30 ml in 1 plastic bottle. 3. No preservative. Additional Information: 1. No specimen substitutions. 2. No STATS are accepted for this procedure. 3. For situations where chain of custody is required, a Chain-of-Custody Kit (Supply T282) is available. For chain-of-custody information, see PDSOX / Pain Clinic Drug Screen, Chain of Custody, Urine. 4. Additional drug panels and specific requests are available. Call Mayo Medical Laboratories at 800-533-1710 or 507-266-5700. 5. If urine creatinine is required or adulteration of the sample is suspected, the following test should be requested, ADULT / Adulterants Survey, Urine. 6. For additional information, please refer to ADULT / Adulterants Survey, Urine. Specimen Type Temperature Time Urine Refrigerated (preferred) 14 days Frozen Ambient 14 days 72 hours Result Codes: Result ID Reporting Name Type Unit LOINC 30909 Alcohol Numeric mg/dl 42242-8 Also used by tests: IDOAU, CDAU, CDAU1, CDAU7 2573 Amphetamines Numeric ng/ml 20410-7 Also used by tests: CDAU5, CDAU2, CDAU7, CDAU3, CDAU, CDAU1 Document generated July 15, 2014 at 10:48am CDT Page 1 of 5

Result ID Reporting Name Type Unit LOINC 2574 Barbiturates Numeric ng/ml 19270-8 Also used by tests: IDOAU, CDAU7, CDAU1, CDAU3, CDAU, CDAU2 2575 Benzodiazepines Numeric ng/ml 20412-3 Also used by tests: CDAU, CDAU3, CDAU7 21652 Cocaine Numeric ng/ml 20519-5 Also used by tests: CDAU2, CDAU7, CDAU1, CDAU5, CDAU, CDAU3 4435 Methadone Numeric ng/ml 16246-1 Also used by tests: CDAU2, CDAU1, CDAU7 2577 Opiates Numeric ng/ml 19295-5 Also used by tests: CDAU5, CDAU, CDAU7, CDAU2, CDAU1, IDOAU, CDAU3 2578 Phencyclidine Numeric ng/ml 19659-2 Also used by tests: CDAU2, CDAU3, CDAU5, CDAU7, IDOAU, CDAU, CDAU1 2664 Tetrahydrocannabinol Numeric ng/ml 3530-3 Also used by tests: CDAU3, CDAU7, CDAU5, CDAU 20672 Chain of Custody Numeric N/A Also used by tests: IDOAU, CDAU1, CDAU7, CDAU3, CDAU5, CDAU2, CDAU 62623 Oxycodone Numeric ng/ml In Process 31260 Drugs detected: Alphanumeric 41270-0 45529 Suspect Drug Alphanumeric In Process 31262 Chain of Custody Numeric N/A Document generated July 15, 2014 at 10:48am CDT Page 2 of 5

Components: Test ID Reporting Name CPT Units CPT Code Always Performed Orderable Separately CDAU7 Confirmed Drug Abuse Panel 9, U 1 80104 Yes Yes OXYSU Oxycodone Screen, U 1 80104 Yes Yes PDSU Drug Screen, Prescription/OTC, U 1 80100 Yes Yes Reflex Tests: Test ID Reporting Name CPT Units CPT Code Always Performed Orderable Separately AMPHU Amphetamines Confirmation, U 2 82145 No Yes COKEU Cocaine and metabolite Conf, U 1 82520 No Yes BENZU Benzodiazepines Confirmation, U 1 80154 No Yes BARBU Barbiturates Confirmation, U 1 82205 No Yes MTDNU Methadone Confirmation, U 1 83840 No Yes PCPU Phencyclidine Confirmation, U 1 83992 No Yes THCU Carboxy-THC Confirmation, U 1 80299 No Yes ETOH Ethanol, U 1 82055 No No OPATU Opiate Confirmation, U 1 83925 No Yes OXYCU Oxycodone w/metabolite Conf, U 1 83925 No Yes Result Codes for Reflex Tests: OPATU 6543 Codeine-by LC-MS/MS Alphanumeric ng/ml 3508-9 OPATU 21177 Hydrocodone-by LC-MS/MS Alphanumeric ng/ml 3681-4 OPATU 21179 Hydromorphone-by LC-MS/MS Alphanumeric ng/ml 9835-0 OPATU 21178 Oxycodone-by LC-MS/MS Alphanumeric ng/ml 11246-6 OPATU 35023 Oxymorphone-by LC-MS/MS Alphanumeric ng/ml In Process OPATU 6542 Morphine-by LC-MS/MS Alphanumeric ng/ml 3831-5 OPATU 21180 Opiates Interpretation Alphanumeric 69050-3 Document generated July 15, 2014 at 10:48am CDT Page 3 of 5

OPATU 21181 Chain of Custody Numeric N/A AMPHU 2934 Amphetamine-by GC/MS Alphanumeric ng/ml 19346-6 AMPHU 29278 Phentermine-by GC/MS Alphanumeric ng/ml 3958-6 AMPHU 2550 Methamphetamine-by GC/MS Alphanumeric ng/ml 3780-4 AMPHU 29279 Pseudoephedrine/Ephedrine-by GC/MS Alphanumeric ng/ml 26785-6 AMPHU 29280 MDA (Ecstasy metabolite)-by GC/MS Alphanumeric ng/ml 18355-8 AMPHU 29281 MDMA (Ecstasy)-by GC/MS Alphanumeric ng/ml 19570-1 AMPHU 21197 Amphetamines Interpretation Alphanumeric 69050-3 AMPHU 20641 Chain of Custody Numeric N/A BARBU 21442 Butalbital-by GC/MS Alphanumeric ng/ml 16237-0 BARBU 20642 Amobarbital-by GC/MS Alphanumeric ng/ml 16239-6 BARBU 20643 Pentobarbital-by GC/MS Alphanumeric ng/ml 16240-4 BARBU 20644 Secobarbital-by GC/MS Alphanumeric ng/ml 16238-8 BARBU 20645 Phenobarbital-by GC/MS Alphanumeric ng/ml 16241-2 BARBU 20651 Barbiturates Interpretation Alphanumeric 69050-3 BARBU 20647 Chain of Custody Numeric N/A BENZU 21441 Nordiazepam-by GC/MS Alphanumeric ng/ml 16228-9 BENZU 20655 Oxazepam-by GC/MS Alphanumeric ng/ml 16201-6 BENZU 20656 Lorazepam-by GC/MS Alphanumeric ng/ml 17088-6 BENZU 20657 Temazepam-by GC/MS Alphanumeric ng/ml 20559-1 BENZU 20658 OH-Ethyl-Flurazepam-by GC/MS Alphanumeric ng/ml 20532-8 BENZU 20659 7-NH-Clonazepam-by GC/MS Alphanumeric ng/ml 51776-3 BENZU 20670 Alpha OH-Alprazolam-by GC/MS Alphanumeric ng/ml 16348-5 BENZU 20660 7-NH-Flunitrazepam-by GC/MS Alphanumeric ng/ml 51777-1 BENZU 20661 Alpha OH-Triazolam-by GC/MS Alphanumeric ng/ml 49876-6 BENZU 20663 Benzodiazepines Interpretation Alphanumeric 69050-3 BENZU 20664 Chain of Custody Numeric N/A COKEU 2922 Cocaine-by GC/MS Alphanumeric ng/ml 3398-5 COKEU 2902 Benzoylecgonine-by GC/MS Alphanumeric ng/ml 3394-4 COKEU 20671 Cocaine Interpretation Alphanumeric 69050-3 COKEU 28080 Chain of Custody Numeric N/A Document generated July 15, 2014 at 10:48am CDT Page 4 of 5

ETOH 30925 Ethanol-by GC-FID Numeric 5645-7 ETOH 24032 Ethanol Interpretation Alphanumeric 69050-3 ETOH 24035 Chain of Custody Numeric N/A MTDNU 56028 EDDP-by GC-MS Alphanumeric ng/ml 50542-0 MTDNU 83129 Methadone-by GC-MS Alphanumeric ng/ml 3774-7 MTDNU 21107 Methadone Interpretation Alphanumeric 69050-3 MTDNU 21110 Chain of Custody Numeric N/A PCPU 6673 Phencyclidine-by GC/MS Alphanumeric ng/ml 16254-5 PCPU 21192 Phencyclidine Interpretation Alphanumeric 69050-3 PCPU 21193 Chain of Custody Numeric N/A THCU 2497 Carboxy-THC- by GC/MS Alphanumeric ng/ml 3530-3 THCU 21186 Carboxy-THC Interpretation Alphanumeric 69050-3 THCU 21187 Chain of Custody Numeric N/A OXYCU 62616 Oxycodone-by LC-MS/MS Alphanumeric ng/ml In Process OXYCU 35965 Oxymorphone-by LC-MS/MS Alphanumeric ng/ml In Process OXYCU 36022 Oxycodone Interpretation Alphanumeric In Process Reference Values: Negative Screening cutoff concentrations: Alcohol: 30 mg/dl Amphetamines: 500 ng/ml Barbiturates: 200 ng/ml Benzodiazepines: 200 ng/ml Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/ml Ethanol: 30 mg/dl Methadone: 150 ng/ml Opiates: 300 ng/ml Phencyclidine: 25 ng/ml Tetrahydrocannabinol carboxylic acid: 20 ng/ml This report is intended for use in clinical monitoring or management of patients. It is not intended for use in employment-related testing. Document generated July 15, 2014 at 10:48am CDT Page 5 of 5